TY  - JOUR
AU  - Acosta, Y Y
AU  - Montes-Casado, Maria
AU  - Aragoneses-Fenoll, Laura
AU  - Dianzani, U
AU  - Portoles, Pilar
AU  - Rojo, J M
PY  - 2014
DO  - 10.1177/039463201402700108
SN  - 0394-6320
UR  - http://hdl.handle.net/20.500.12105/10237
AB  - Class IA phosphatidyl inositol-3 kinases (PI3-K) are important targets in cancer therapy and are essential to immune responses, particularly through costimulation by CD28 and ICOS. Thus, small PI3-K inhibitors are likely candidates to immune...
LA  - eng
PB  - SAGE Publishing
KW  - Animals
KW  - Apoptosis
KW  - CD4-Positive T-Lymphocytes
KW  - Cells, Cultured
KW  - Cytokines
KW  - Dose-Response Relationship, Drug
KW  - Encephalomyelitis, Autoimmune, Experimental
KW  - Female
KW  - Hydrazones
KW  - Lymphocyte Activation
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Sulfonamides
KW  - Phosphoinositide-3 Kinase Inhibitors
TI  - Suppression of CD4+ T lymphocyte activation in vitro and experimental encephalomyelitis in vivo by the phosphatidyl inositol 3-kinase inhibitor PIK-75
TY  - journal article
ER  -